Literature DB >> 3289745

Scintigraphic detection in mice of inflammatory lesions and tumours by an indium-labelled monoclonal antibody directed against Mac-1 antigen.

B Collet1, P Pellen, A Martin, A Moisan, D Bourel, L Toujas.   

Abstract

The monoclonal antibody, 3A33, directed against Mac-1 antigen which is expressed essentially on macrophages and polymorphonuclear cells, was injected i.v. into mice, as part of an attempt to visualize inflammatory lesions and tumours by external scintigraphy. The monoclonal antibody, a rat IgG2a, was conjugated with a bifunctional chelating agent, diethylenetriaminepentaacetic acid at a 1:1 molecular ratio and complexed with 111-indium, a procedure which apparently did not alter its binding to peritoneal macrophages and provided relatively stable cell labelling. An unrelated rat IgG2a of unknown specificity radiolabelled in the same manner as 3A33 served as a control. The uptake of i.v. injected 3A33 by peritoneal macrophages was up to 50 times that of unrelated IgG2a. After i.v. inoculation, the antibody accumulated in the liver, spleen, lung, in foot-pad inflammatory reactions induced by injection of Freund's adjuvant and in experimentally grafted tumours. The 3A33: non-specific IgG2a uptake ratio in inflammatory lesions and tumours, however, was much lower than for peritoneal macrophages and was generally close to 2. This was sufficient to obtain scintigraphic images of inflammations and tumours. The images obtained after injection of 3A33 were clearly of better quality than those given by the non-specific immunoglobulin. They could be improved by subtraction of the vascular images obtained after injection of 99m-technetium serum albumin. The labelling of Mac-1-positive blood mononuclear cells by in vitro incubation with radioactive 3A33 was not intense enough to allow scintigraphic imaging after in vivo re-infusion but seemed more selective than the injection of whole antibody in detecting inflammatory reactions. These results seem interesting in view of the potential human application to the detection inflammatory lesions and the appreciation of tumour inflammatory components. Possible improvements in the technique are discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3289745     DOI: 10.1007/bf00199935

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  13 in total

1.  Macrophage heterogeneity in receptor activity: the activation of macrophage Fc receptor function in vivo and in vitro.

Authors:  J Rhodes
Journal:  J Immunol       Date:  1975-03       Impact factor: 5.422

2.  A monoclonal antibody (3A33) that reacts with a mouse-specific epitope of Mac-1 antigen.

Authors:  A Martin; R Le Corre; P Pellen; D Bourel; G Merdrignac; B Genetet; L Toujas
Journal:  Tissue Antigens       Date:  1986-07

3.  Indium 111 autologous granulocytes in the diagnosis of abscess and in the assessment of inflammatory bowel disease.

Authors:  J Y Herry; A Moisan; J Le Cloirec; J F Bretagne; P Darnault; J L Cardin; A Martin
Journal:  Int J Rad Appl Instrum B       Date:  1986

4.  Effect of DTPA conjugation on the antigen binding activity and biodistribution of monoclonal antibodies against alpha-fetoprotein.

Authors:  H Sakahara; K Endo; T Nakashima; M Koizumi; H Ohta; K Torizuka; T Furukawa; Y Ohmomo; A Yokoyama; K Okada
Journal:  J Nucl Med       Date:  1985-07       Impact factor: 10.057

5.  Use of radiolabelled monoclonal anti-CEA antibodies for the detection of human carcinomas by external photoscanning and tomoscintigraphy.

Authors:  J P Mach; F Buchegger; M Forni; J Ritschard; C Berche; J D Lumbroso; M Schreyer; C Girardet; R S Accolla; S Carrel
Journal:  Immunol Today       Date:  1981-12

6.  Resistance to tumor graft in mice treated with inactivated Brucella abortus cultured in smooth or rough phase.

Authors:  A Martin; L Toujas; Y Le Garrec; L Dazord; J Amice
Journal:  J Natl Cancer Inst       Date:  1979-01       Impact factor: 13.506

7.  High-specific-activity 111In-labeled anticarcinoembryonic antigen monoclonal antibody: improved method for the synthesis of diethylenetriaminepentaacetic acid conjugates.

Authors:  R J Paxton; J G Jakowatz; J D Beatty; B G Beatty; W G Vlahos; L E Williams; B R Clark; J E Shively
Journal:  Cancer Res       Date:  1985-11       Impact factor: 12.701

8.  Modulation of expression of mouse macrophage surface antigens by monoclonal antibodies.

Authors:  B Collet; A Martin; G Merdrignac; B Genetet; L Toujas
Journal:  Immunology       Date:  1985-11       Impact factor: 7.397

9.  Quantitative study on the production and kinetics of mononuclear phagocytes during an acute inflammatory reaction.

Authors:  R Van Furth; M C Diesselhoff-den Dulk; H Mattie
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

10.  Anti-Mac-1 selectively inhibits the mouse and human type three complement receptor.

Authors:  D I Beller; T A Springer; R D Schreiber
Journal:  J Exp Med       Date:  1982-10-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.